Cargando…
Inflammation, Biomarkers and Immuno-Oncology Pathways in Pancreatic Cancer
It is estimated that pancreatic cancer will be the second leading cause of cancer-related deaths globally by 2030, highlighting the ongoing lack of effective treatment options for this devastating condition. There is a lack of reliable prognostic or predictive markers in pancreatic cancer to guide m...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616860/ https://www.ncbi.nlm.nih.gov/pubmed/31035449 http://dx.doi.org/10.3390/jpm9020020 |